Axon Enterprise (AXON) Projected to Announce Quarterly Earnings on Thursday

Key Points

• Axon Enterprise is expected to report Q3 2026 results on November 5 after the market closes, with analysts forecasting $1.89 in EPS and $936.95 million in revenue.
• The company’s latest quarter exceeded expectations, with EPS of $1.88 versus a $1.84 estimate and revenue of $904.39 million, up 35.3% year over year.
• Despite a recent share-price decline and elevated valuation, Wall Street maintains a “Moderate Buy” consensus with an average price target of $688.38; insiders have sold nearly $26.7 million of stock over the past 90 days.

Axon Enterprise (NASDAQ:AXON - Get Free Report) is projected to issue its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to announce earnings of $1.89 per share and revenue of $936.95 million for the quarter. Interested persons may review the information on the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same period last year, the business posted $2.12 earnings per share. The business's revenue for the quarter was up 35.3% compared to the same quarter last year. On average, analysts expect Axon Enterprise to post $2.10 EPS for the current fiscal year and $4.59 EPS for the next fiscal year.

Axon Enterprise Trading Down 0.6%

Shares of NASDAQ:AXON opened at $423.17 on Thursday. Axon Enterprise has a 12-month low of $339.01 and a 12-month high of $762.08. The stock has a market cap of $34.38 billion, a PE ratio of 175.59, a P/E/G ratio of 7.99 and a beta of 1.44. The business has a 50 day moving average of $471.32 and a 200-day moving average of $483.20. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of recent research reports. Northcoast Research increased their target price on Axon Enterprise from $650.00 to $680.00 and gave the stock a "buy" rating in a research note on Tuesday, August 11th. The Goldman Sachs Group reduced their price target on Axon Enterprise from $715.00 to $675.00 and set a "buy" rating for the company in a research note on Monday, September 21st. UBS Group boosted their price target on Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Needham & Company LLC reaffirmed a "buy" rating on shares of Axon Enterprise in a report on Tuesday. Finally, Piper Sandler lowered their price objective on Axon Enterprise from $732.00 to $561.00 and set an "overweight" rating on the stock in a research report on Tuesday, October 20th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $688.38.

Insider Buying and Selling at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 9,605 shares of the business's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares in the company, valued at approximately $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. This represents a 5.35% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 47,397 shares of company stock valued at $26,722,984 over the last ninety days. Company insiders own 4.20% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.